Dr Karen O’Hanlon joined Boyds in 2019 as the Vice President, Clinical Operations.
Karen has more than 19 years’ experience in preclinical, clinical and analytical drug development and has a strong track record of leading experienced project teams across all functions. Karen has expertise across multiple therapeutic areas including the clinical development of oncology, gene therapies and vaccine products.
Previously, Karen owned Blue Duck Consultancy Ltd which she set up in 2013 to provide program and project management for preclinical and clinical phase I-IV studies through a global network of CRA consultants. Karen’s role involved the oversight and management of a team of global CRAs to support clients with study start up activities, clinical study monitoring, feasibility studies, medical writing and training.
Karen’s career has spanned various project management roles including Project Director at hVIVO, Clinical and Laboratory Project Manager and Feasibility and Program Manager at SRA Global Clinical Development and Preclinical and Clinical Project Manager at MediGene GmbH.
Prior to this, Karen was a Consultant Project Manager (veterinary medicine) at Triveritas and a Preclinical Business Co-Ordinator (Program Manager) and Project Leader (in vivo metabolism) at Charles River Laboratories.
Karen completed her post-doctoral research at the Wellcome Trust Centre for Cell Matrix Research in Manchester.
She has a BSc (Hons) in Medical Biochemistry from the University of Glasgow and a PhD in Biochemistry from the University of Manchester.